Cytosorbents (CTSO) Revenue (QoQ) (2012 - 2026)
Cytosorbents (CTSO) Revenue (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn |
| 10 | Cytosorbents | 22.51 Mn | 17.71 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.01% |
| Dec 31, 2025 | -2.65% |
| Sep 30, 2025 | -1.37% |
| Jun 30, 2025 | 10.20% |
| Mar 31, 2025 | -4.63% |
| Dec 31, 2024 | 6.25% |
| Sep 30, 2024 | -2.59% |
| Jun 30, 2024 | -1.64% |
| Mar 31, 2024 | 3.71% |
| Dec 31, 2023 | -1.62% |
| Sep 30, 2023 | -6.47% |
| Jun 30, 2023 | -0.30% |
| Mar 31, 2023 | 0.63% |
| Dec 31, 2022 | 15.77% |
| Sep 30, 2022 | -4.52% |
| Jun 30, 2022 | -2.25% |
| Mar 31, 2022 | -19.39% |
| Dec 31, 2021 | 10.47% |
| Sep 30, 2021 | -18.83% |
| Jun 30, 2021 | 13.45% |